Trial 3C-16-6


Randomized Phase III Trial of 5-FU Based Maintenance Therapy with or without Panitumumab in Patients with RAS WT Metastatic Colorectal Cancer after Induction with FOLFOX + Panitumumab

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic, Other
Randomized: Yes
USC Satellite Location: USC Newport Beach Oncology
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Afsaneh Barzi, M.D.
Other Trial Staff:  Ramona Lujan, Coordinator, Fahim Raian, D.M., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Marile Garcia, Coordinator, Kristy Sartor Massopust, Coordinator, Yanli Wang, D.M., Rabia Rehman, Coordinator, Diana Oganyesyan, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.